Adenosine-dopamine interactions revealed in knockout mice

Journal of Molecular Neuroscience

Volumn 26, Issue 2-3, 2005, Pages 239-244

  Salmi, Peter ^a   Chergui, Karima ^a   Fredholm, Bertil B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adenosine; Caffeine; Dopamine; Knockout; Mouse

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; CAFFEINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR;

BASAL GANGLION; BRAIN NERVE CELL; CONFERENCE PAPER; DOPAMINE RECEPTOR BLOCKING; DOPAMINERGIC TRANSMISSION; DRUG TARGETING; KNOCKOUT MOUSE; MOLECULAR INTERACTION; MOTOR PERFORMANCE; NERVE DEGENERATION; NEUROCHEMISTRY; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRESYNAPTIC INHIBITION; SIGNAL TRANSDUCTION; WILD TYPE;

ADENOSINE; ANIMALS; DOPAMINE; MICE; MICE, KNOCKOUT; RECEPTOR, ADENOSINE A2A; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D2; RECEPTORS, PURINERGIC P1;

EID: 25844500359     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:26:2-3:239     Document Type: Conference Paper

References (35)

1. Calabresi P., Centonze D., Pisani A., and Bernardi G. (1997) Endogenous adenosine mediates the presynaptic inhibition induced by aglycemia at corticostriatal synapses. J. Neurosci. 17, 4509-4516.
2. Chen J. F. (2003) The adenosine A(2A) receptor as an attractive target for Parkinson's disease treatment. Drug News Perspect. 16, 597-604.
3. Chen J. F., Moratalla R., Impagnatiello F., Grandy D. K., Cuellar B., Rubinstein M., et al. (2001a) The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Proc. Natl. Acad. Sci. U. S. A. 98, 1970-1975.
4. Chen J. F., Xu K., Petzer J. P., Staal R., Xu Y. H., Beilstein M., et al. (2001b) Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease. J. Neurosci. 21, RC143.
5. Corvol J. C., Studler J. M., Schonn J. S., Girault J. A., and Herve D. (2001) Galpha(olf) is necessary for coupling D1 and A2a receptors to adenylyl cyclase in the striatum. J. Neurochem. 76, 1585-1588.
6. Dunwiddie T. V. and Masino S. A. (2001) The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24, 31-55.
7. El Yacoubi M., Ledent C., Menard J. F., Parmentier M., Costentin J., and Vaugeois J. M. (2000) The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors. Br. J. Pharmacol. 129, 1465-1473.
8. El Yacoubi M., Ledent C., Parmentier M., Costentin J., and Vaugeois J. M. (2001) Adenosine A2A receptor knockout mice are partially protected against drug-induced catalepsy. Neuroreport 12, 983-986.
9. Ferré S., Fredholm B. B., Morelli M., Popoli P., and Fuxe K. (1997) Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20, 482-487.
10. 2 receptors in rat striatal membranes. Proc. Natl. Acad. Sci. U. S. A. 88, 7238-7241.
11. Flagmeyer I., Haas H. L., and Stevens D. R. (1997) Adenosine A1 receptor-mediated depression of corticostriatal and thalamostriatal glutamatergic synaptic potentials in vitro. Brain Res. 778, 178-185.
12. Fredholm B.B. and Dunwiddie T. V. (1988) How does adenosine inhibit transmitter release? Trends Pharmacol. Sci. 9, 130-134.
13. Fredholm B. B. and Svenningsson P. (2003) Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities. Neurology 61(Suppl. 6), S5-S9.
14. Fredholm B. B., Bättig K., Holmén J., Nehlig A., and Zvartau E. (1999) Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51, 83-153.
15. 2A receptors and therapeutic applications. Curr. Top. Med. Chem. 3, 413-426.
16. Fuxe K. and Ungerstedt U. (1974) Action of caffeine and theophyllamine on supersensitive dopamine receptors: considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists. Med. Biol. 52, 48-54.
17. Fuxe K., Strömberg I., Popoli P., Rimondini-Giorgini R., Torvinen M., Ogren S. O., et al. (2001) Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum. Adv. Neurol. 86, 345-353.
18. Glatt C. E. and Snyder S. H. (1993) Cloning and expression of an adenylyl cyclase localized to the corpus striatum. Nature 361, 536-538.
19. 2A receptors. Neuropharmacology 46, 1008-1017.
20. Hervé D., Le Moine C., Corvol J. C., Belluscio L., Ledent C., Fienberg A. A., et al. (2001) Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum. J. Neurosci. 21, 4390-4399.
21. Jones D. T., Masters S. B., Bourne H. R., and Reed R. R. (1990) Biochemical characterization of three stimulatory GTP-binding proteins. The large and small forms of Gs and the olfactory-specific G-protein, Golf. J. Biol. Chem. 265, 2671-2676.
22. Kim D. S. and Palmiter R. D. (2003) Adenosine receptor blockade reverses hypophagia and enhances locomotor activity of dopamine-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 100, 1346-1351.
23. olf in rat striatum. Mol. Pharmacol. 58, 771-777.
24. Lee K. W., Hong J. H., Choi I. Y., Che Y., Lee J. K., Yang S. D., et al. (2002) Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase. J. Neurosci. 22, 7931-7940.
25. Lindskog M., Svenningsson P., Pozzi L., Kim Y., Fienberg A. A., Bibb J. A., et al. (2002) Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine. Nature 418, 774-778.
26. 1 receptors. J. Pharmacol. Exp. Ther. 303, 356-363.
27. Moore K. A., Nicoll R. A., and Schmitz D. (2003) Adenosine gates synaptic plasticity at hippocampal mossy fiber synapses. Proc. Natl. Acad. Sci. U. S. A. 100, 14397-14402.
28. Scammell T. E., Arrigoni E., Thompson M. A., Ronan P. J., Saper C. B., and Greene R. W. (2003) Focal deletion of the adenosine A1 receptor in adult mice using an adeno-associated viral vector. J. Neurosci. 23, 5762-5770.
29. Solinas M., Ferré S., You Z. B., Karcz-Kubicha M., Popoli P., and Goldberg S. R. (2002) Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J. Neurosci. 22, 6321-6324.
30. Svenningsson P., Fourreau L., Bloch B., Fredholm B. B., Gonon F., and Le Moine C. (1999a) Opposite tonic modulation of dopamine and adenosine on c-fos mRNA expression in striatopallidal neurons. Neuroscience 89, 827-837.
31. Svenningsson P., Le Moine C., Fisone G., and Fredholm B. B. (1999a) Distribution, biochemistry and function of striatal adenosine A2Areceptors. Prog. Neurobiol. 59, 355-396.
32. 2A receptors. Proc. Natl. Acad. Sci. U. S. A. 97, 1856-1860.
33. 1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons. Neuroscience 84, 223-228.
34. 2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens. Neuroscience 79, 753-764.
35. 2 receptors. J. Neurosci. 20, 5949-5957.